Incyte Corporation
USD114.66
+0.91 (+0.80%)
CEO
William J. Meury
IPO Date
1993-11-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$113.99
Prev. Close
$113.75
Day Low
$112.89
Day High
$115.48
52W Low
$66.83
52W High
$115.56
Market Cap
$22.91B
Volume
1.40M
| 438.6 |
| 31 Dec 2023 | FY | 93.1% | 16.2% | 11.5% | 8.8% | 0.01 | 3.75 | 23.5 |
| 31 Dec 2022 | FY | 93.9% | 10.0% | 7.8% | 5.8% | 0.01 | 3.54 | 52.3 |
| 31 Dec 2021 | FY | 94.9% | 31.8% | 25.2% | 19.2% | 0.01 | 3.65 | 17.1 |
| 31 Dec 2020 | FY | 95.1% | -11.1% | -11.3% | -8.3% | 0.02 | 3.74 | -64.1 |
| 31 Dec 2019 | FY | 94.7% | 20.7% | 17.2% | 13.0% | 0.02 | 4.83 | 42.0 |
| 31 Dec 2018 | FY | 95.0% | 5.8% | 5.7% | 4.1% | 0.02 | 4.31 | 123.3 |
| 31 Dec 2017 | FY | 94.8% | -20.4% | -19.2% | -13.6% | 0.01 | 4.01 | -61.9 |
| 31 Dec 2016 | FY | 94.7% | 9.4% | 24.8% | 6.4% | 1.55 | 3.64 | 180.7 |
| 16.3 |
| 30 Sept 2025 | Q3 | 92.8% | 31.1% | 9.1% | 6.7% | 0.01 | 3.20 | 9.8 |
| 30 Jun 2025 | Q2 | 93.5% | 33.3% | 9.7% | 7.0% | 0.01 | 2.85 | 8.2 |
| 31 Mar 2025 | Q1 | 93.0% | 15.0% | 4.3% | 2.8% | 0.01 | 2.04 | 18.5 |
| 31 Dec 2024 | Q4 | 92.5% | 17.1% | 5.8% | 3.7% | 0.01 | 1.97 | 16.6 |
| 30 Sept 2024 | Q3 | 92.4% | 9.4% | 3.4% | 2.1% | 0.01 | 1.87 | 29.9 |
| 30 Jun 2024 | Q2 | 92.7% | -42.6% | -14.8% | -9.5% | 0.01 | 1.92 | -7.5 |
| 31 Mar 2024 | Q1 | 93.1% | 19.2% | 3.1% | 2.4% | 0.01 | 3.47 | 18.7 |
| 31 Dec 2023 | Q4 | 93.1% | 19.8% | 3.9% | 3.0% | 0.01 | 3.75 | 17.5 |